カテゴリー： GlobalInfoResearch, 世界

バイオ医薬品およびワクチン生産の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Biopharmaceutical and Vaccine Production Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9103412）・商品コード：GIR9103412
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月26日（※2024年版があります。お問い合わせください）
・ページ数：118
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、バイオ医薬品およびワクチン生産の世界市場について調べ、まとめました。種類別セグメントは、バイオ医薬品、ワクチン製造等、用途別セグメントは、医薬品、バイオテクノロジー、学術研究機関、その他等に区分しました。バイオ医薬品およびワクチン生産の世界市場概観、企業動向、企業別バイオ医薬品およびワクチン生産シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・バイオ医薬品およびワクチン生産の市場概観
・バイオ医薬品およびワクチン生産の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・バイオ医薬品およびワクチン生産の企業別販売動向、市場シェア、市場集中度、競争動向
・バイオ医薬品およびワクチン生産の世界市場規模
・バイオ医薬品およびワクチン生産の北米市場分析（アメリカ、カナダ、メキシコ等）
・バイオ医薬品およびワクチン生産のアメリカ市場規模推移
・バイオ医薬品およびワクチン生産のカナダ市場規模推移
・バイオ医薬品およびワクチン生産のメキシコ市場規模推移
・バイオ医薬品およびワクチン生産のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・バイオ医薬品およびワクチン生産のドイツ市場規模推移
・バイオ医薬品およびワクチン生産のイギリス市場規模推移
・バイオ医薬品およびワクチン生産のロシア市場規模推移
・バイオ医薬品およびワクチン生産のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・バイオ医薬品およびワクチン生産の日本市場規模推移
・バイオ医薬品およびワクチン生産の中国市場規模推移
・バイオ医薬品およびワクチン生産の韓国市場規模推移
・バイオ医薬品およびワクチン生産のインド市場規模推移
・バイオ医薬品およびワクチン生産の東南アジア市場規模推移
・バイオ医薬品およびワクチン生産の南米市場分析（ブラジル、アルゼンチン等）
・バイオ医薬品およびワクチン生産の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・バイオ医薬品およびワクチン生産の種類別分析/販売量、売上、市場シェア（バイオ医薬品、ワクチン製造）
・バイオ医薬品およびワクチン生産の用途別分析/市場規模（医薬品、バイオテクノロジー、学術研究機関、その他）
・バイオ医薬品およびワクチン生産の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・バイオ医薬品およびワクチン生産の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Biopharmaceutical is a pharmaceutical derived from biological sources and especially one produced by biotechnology. A vaccine is a biological preparation that provides active acquired immunity to a particular disease.

Scope of the Report:
The global Biopharmaceutical and Vaccine Production market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biopharmaceutical and Vaccine Production.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Biopharmaceutical and Vaccine Production market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biopharmaceutical and Vaccine Production market by product type and applications/end industries.

Market Segment by Companies, this report covers
Novartis
Pfizer
Sanofi
Roche
Abbott
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
FUJIFILM Diosynth Biotechnologies

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Biopharmaceutical
Vaccine Production

Market Segment by Applications, can be divided into
Pharmaceutical
Biotechnology
Academic and Research Institutes
Others

【レポートの目次】

Table of Contents

1 Biopharmaceutical and Vaccine Production Market Overview
1.1 Product Overview and Scope of Biopharmaceutical and Vaccine Production
1.2 Classification of Biopharmaceutical and Vaccine Production by Types
1.2.1 Global Biopharmaceutical and Vaccine Production Revenue Comparison by Types (2019-2024)
1.2.2 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Types in 2018
1.2.3 Biopharmaceutical
1.2.4 Vaccine Production
1.3 Global Biopharmaceutical and Vaccine Production Market by Application
1.3.1 Global Biopharmaceutical and Vaccine Production Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Academic and Research Institutes
1.3.5 Others
1.4 Global Biopharmaceutical and Vaccine Production Market by Regions
1.4.1 Global Biopharmaceutical and Vaccine Production Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Biopharmaceutical and Vaccine Production Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biopharmaceutical and Vaccine Production Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biopharmaceutical and Vaccine Production Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Biopharmaceutical and Vaccine Production Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biopharmaceutical and Vaccine Production Status and Prospect (2014-2024)
1.5 Global Market Size of Biopharmaceutical and Vaccine Production (2014-2024)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Biopharmaceutical and Vaccine Production Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Biopharmaceutical and Vaccine Production Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Biopharmaceutical and Vaccine Production Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 Biopharmaceutical and Vaccine Production Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbott
2.5.1 Business Overview
2.5.2 Biopharmaceutical and Vaccine Production Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.6 Regeneron Pharmaceuticals
2.6.1 Business Overview
2.6.2 Biopharmaceutical and Vaccine Production Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.7 Alexion Pharmaceuticals
2.7.1 Business Overview
2.7.2 Biopharmaceutical and Vaccine Production Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.8 Johnson and Johnson
2.8.1 Business Overview
2.8.2 Biopharmaceutical and Vaccine Production Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.9 GlaxoSmithKline
2.9.1 Business Overview
2.9.2 Biopharmaceutical and Vaccine Production Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.10 Merck
2.10.1 Business Overview
2.10.2 Biopharmaceutical and Vaccine Production Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Merck Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.11 Lonza
2.11.1 Business Overview
2.11.2 Biopharmaceutical and Vaccine Production Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Lonza Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
2.12 FUJIFILM Diosynth Biotechnologies
2.12.1 Business Overview
2.12.2 Biopharmaceutical and Vaccine Production Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biopharmaceutical and Vaccine Production Market Competition, by Players
3.1 Global Biopharmaceutical and Vaccine Production Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Biopharmaceutical and Vaccine Production Players Market Share
3.2.2 Top 10 Biopharmaceutical and Vaccine Production Players Market Share
3.3 Market Competition Trend
4 Global Biopharmaceutical and Vaccine Production Market Size by Regions
4.1 Global Biopharmaceutical and Vaccine Production Revenue and Market Share by Regions
4.2 North America Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
4.3 Europe Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
4.5 South America Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
5 North America Biopharmaceutical and Vaccine Production Revenue by Countries
5.1 North America Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
5.2 USA Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
5.3 Canada Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
5.4 Mexico Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
6 Europe Biopharmaceutical and Vaccine Production Revenue by Countries
6.1 Europe Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
6.2 Germany Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
6.3 UK Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
6.4 France Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
6.5 Russia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
6.6 Italy Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue by Countries
7.1 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
7.2 China Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
7.3 Japan Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
7.4 Korea Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
7.5 India Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
8 South America Biopharmaceutical and Vaccine Production Revenue by Countries
8.1 South America Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
8.2 Brazil Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
8.3 Argentina Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
8.4 Colombia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Biopharmaceutical and Vaccine Production by Countries
9.1 Middle East and Africa Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
9.2 Saudi Arabia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
9.3 UAE Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
9.4 Egypt Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
9.5 Nigeria Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
9.6 South Africa Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
10 Global Biopharmaceutical and Vaccine Production Market Segment by Type
10.1 Global Biopharmaceutical and Vaccine Production Revenue and Market Share by Type (2014-2019)
10.2 Global Biopharmaceutical and Vaccine Production Market Forecast by Type (2019-2024)
10.3 Biopharmaceutical Revenue Growth Rate (2014-2024)
10.4 Vaccine Production Revenue Growth Rate (2014-2024)
11 Global Biopharmaceutical and Vaccine Production Market Segment by Application
11.1 Global Biopharmaceutical and Vaccine Production Revenue Market Share by Application (2014-2019)
11.2 Biopharmaceutical and Vaccine Production Market Forecast by Application (2019-2024)
11.3 Pharmaceutical Revenue Growth (2014-2019)
11.4 Biotechnology Revenue Growth (2014-2019)
11.5 Academic and Research Institutes Revenue Growth (2014-2019)
11.6 Others Revenue Growth (2014-2019)
12 Global Biopharmaceutical and Vaccine Production Market Size Forecast (2019-2024)
12.1 Global Biopharmaceutical and Vaccine Production Market Size Forecast (2019-2024)
12.2 Global Biopharmaceutical and Vaccine Production Market Forecast by Regions (2019-2024)
12.3 North America Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
12.4 Europe Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
12.6 South America Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Biopharmaceutical and Vaccine Production Picture
Table Product Specifications of Biopharmaceutical and Vaccine Production
Table Global Biopharmaceutical and Vaccine Production and Revenue (Million USD) Market Split by Product Type
Figure Global Biopharmaceutical and Vaccine Production Revenue Market Share by Types in 2018
Figure Biopharmaceutical Picture
Figure Vaccine Production Picture
Table Global Biopharmaceutical and Vaccine Production Revenue (Million USD) by Application (2014-2024)
Figure Biopharmaceutical and Vaccine Production Revenue Market Share by Applications in 2018
Figure Pharmaceutical Picture
Figure Biotechnology Picture
Figure Academic and Research Institutes Picture
Figure Others Picture
Table Global Market Biopharmaceutical and Vaccine Production Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Biopharmaceutical and Vaccine Production Type and Applications
Table Novartis Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Biopharmaceutical and Vaccine Production Type and Applications
Table Pfizer Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Biopharmaceutical and Vaccine Production Type and Applications
Table Sanofi Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Biopharmaceutical and Vaccine Production Type and Applications
Table Roche Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Biopharmaceutical and Vaccine Production Type and Applications
Table Abbott Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Type and Applications
Table Regeneron Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Type and Applications
Table Alexion Pharmaceuticals Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson and Johnson Biopharmaceutical and Vaccine Production Type and Applications
Table Johnson and Johnson Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Biopharmaceutical and Vaccine Production Type and Applications
Table GlaxoSmithKline Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Biopharmaceutical and Vaccine Production Type and Applications
Table Merck Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table Lonza Basic Information, Manufacturing Base and Competitors
Table Lonza Biopharmaceutical and Vaccine Production Type and Applications
Table Lonza Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table FUJIFILM Diosynth Biotechnologies Basic Information, Manufacturing Base and Competitors
Table FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Type and Applications
Table FUJIFILM Diosynth Biotechnologies Biopharmaceutical and Vaccine Production Revenue, Gross Margin and Market Share (2017-2018)
Table Global Biopharmaceutical and Vaccine Production Revenue (Million USD) by Players (2014-2019)
Table Global Biopharmaceutical and Vaccine Production Revenue Share by Players (2014-2019)
Figure Global Biopharmaceutical and Vaccine Production Revenue Share by Players in 2017
Figure Global Biopharmaceutical and Vaccine Production Revenue Share by Players in 2018
Figure Global Top 5 Players Biopharmaceutical and Vaccine Production Revenue Market Share in 2018
Figure Global Top 10 Players Biopharmaceutical and Vaccine Production Revenue Market Share in 2018
Figure Global Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Biopharmaceutical and Vaccine Production Revenue (Million USD) by Regions (2014-2019)
Table Global Biopharmaceutical and Vaccine Production Revenue Market Share by Regions (2014-2019)
Figure Global Biopharmaceutical and Vaccine Production Revenue Market Share by Regions (2014-2019)
Figure Global Biopharmaceutical and Vaccine Production Revenue Market Share by Regions in 2018
Figure North America Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Europe Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure South America Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Table North America Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
Table North America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2014-2019)
Figure North America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2014-2019)
Figure North America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries in 2018
Figure USA Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Canada Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Mexico Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Table Europe Biopharmaceutical and Vaccine Production Revenue (Million USD) by Countries (2014-2019)
Figure Europe Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2014-2019)
Figure Europe Biopharmaceutical and Vaccine Production Revenue Market Share by Countries in 2018
Figure Germany Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure UK Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure France Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Russia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Italy Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Biopharmaceutical and Vaccine Production Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Biopharmaceutical and Vaccine Production Revenue Market Share by Countries in 2018
Figure China Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Japan Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Korea Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure India Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Table South America Biopharmaceutical and Vaccine Production Revenue by Countries (2014-2019)
Table South America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2014-2019)
Figure South America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2014-2019)
Figure South America Biopharmaceutical and Vaccine Production Revenue Market Share by Countries in 2018
Figure Brazil Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Argentina Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Colombia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Biopharmaceutical and Vaccine Production Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Biopharmaceutical and Vaccine Production Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Biopharmaceutical and Vaccine Production Revenue Market Share by Countries in 2018
Figure Saudi Arabia Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure UAE Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Egypt Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure Nigeria Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Figure South Africa Biopharmaceutical and Vaccine Production Revenue and Growth Rate (2014-2019)
Table Global Biopharmaceutical and Vaccine Production Revenue (Million USD) by Type (2014-2019)
Table Global Biopharmaceutical and Vaccine Production Revenue Share by Type (2014-2019)
Figure Global Biopharmaceutical and Vaccine Production Revenue Share by Type (2014-2019)
Figure Global Biopharmaceutical and Vaccine Production Revenue Share by Type in 2019
Table Global Biopharmaceutical and Vaccine Production Revenue Forecast by Type (2019-2024)
Figure Global Biopharmaceutical and Vaccine Production Market Share Forecast by Type (2019-2024)
Figure Global Biopharmaceutical Revenue Growth Rate (2014-2019)
Figure Global Vaccine Production Revenue Growth Rate (2014-2019)
Table Global Biopharmaceutical and Vaccine Production Revenue by Application (2014-2019)
Table Global Biopharmaceutical and Vaccine Production Revenue Share by Application (2014-2019)
Figure Global Biopharmaceutical and Vaccine Production Revenue Share by Application (2014-2019)
Figure Global Biopharmaceutical and Vaccine Production Revenue Share by Application in 2019
Table Global Biopharmaceutical and Vaccine Production Revenue Forecast by Application (2019-2024)
Figure Global Biopharmaceutical and Vaccine Production Market Share Forecast by Application (2019-2024)
Figure Global Pharmaceutical Revenue Growth Rate (2014-2019)
Figure Global Biotechnology Revenue Growth Rate (2014-2019)
Figure Global Academic and Research Institutes Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Biopharmaceutical and Vaccine Production Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Biopharmaceutical and Vaccine Production Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Biopharmaceutical and Vaccine Production Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
Figure Europe Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
Figure South America Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Biopharmaceutical and Vaccine Production Revenue Market Forecast (2019-2024)


【掲載企業】

Novartis、Pfizer、Sanofi、Roche、Abbott、Regeneron Pharmaceuticals、Alexion Pharmaceuticals、Johnson and Johnson、GlaxoSmithKline、Merck、Lonza、FUJIFILM Diosynth Biotechnologies、

★調査レポート[バイオ医薬品およびワクチン生産の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9103412)販売に関する免責事項を必ずご確認ください。
★調査レポート[バイオ医薬品およびワクチン生産の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • バイオ医薬品およびワクチンの世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102920 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、バイオ医薬品およびワクチンの世界市場について調べ、まとめました。種類別セグメントは、バイオ医薬品、ワクチン製造等、用途別セグメントは、製薬産業、臨床診断、科学研究、その他等に区分しました。バイオ医薬品およびワクチンの世界市場概観、企業動向、企業別バイオ医薬品およびワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・バイオ医薬品およびワクチンの市場概観 ・バイオ医薬品およびワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・バイオ医薬品およびワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・バイオ医薬品およびワクチンの世界市場規模 ・バイオ医薬品およびワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・バイオ医薬品およびワクチンのアメリカ市場規模推移 ・バイオ医薬品およびワクチンのカナダ市場規模推移 ・バイオ医薬品およびワクチンのメキシコ市場規模推移 ・バイオ医薬品およびワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases. Scope of the Report: The global Biopharmaceutical and Vaccines market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still...
  • バイオ医薬品ドラッグデリバリー技術の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102918 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、バイオ医薬品ドラッグデリバリー技術の世界市場について調べ、まとめました。種類別セグメントは、人間、動物等、用途別セグメントは、製薬産業、臨床診断、科学研究、その他等に区分しました。バイオ医薬品ドラッグデリバリー技術の世界市場概観、企業動向、企業別バイオ医薬品ドラッグデリバリー技術シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・バイオ医薬品ドラッグデリバリー技術の市場概観 ・バイオ医薬品ドラッグデリバリー技術の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・バイオ医薬品ドラッグデリバリー技術の企業別販売動向、市場シェア、市場集中度、競争動向 ・バイオ医薬品ドラッグデリバリー技術の世界市場規模 ・バイオ医薬品ドラッグデリバリー技術の北米市場分析（アメリカ、カナダ、メキシコ等） ・バイオ医薬品ドラッグデリバリー技術のアメリカ市場規模推移 ・バイオ医薬品ドラッグデリバリー技術のカナダ市場規模推移 ・バイオ医薬品ドラッグデリバリー技術のメキシコ市場規模推移 ・バイオ医薬品ドラッグデリバリー技術のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Scope of the Report: The global Biopharmaceutical Drug Delivery Technologies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be...
  • mRNAワクチンおよび治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100023 / GlobalInfoResearch / 2019年10月9日 / 本調査レポートは、mRNAワクチンおよび治療薬の世界市場について調べ、まとめました。種類別セグメントは、感染症、がん、その他等、用途別セグメントは、病院、研究機関等に区分しました。mRNAワクチンおよび治療薬の世界市場概観、企業動向、企業別mRNAワクチンおよび治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・mRNAワクチンおよび治療薬の市場概観 ・mRNAワクチンおよび治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・mRNAワクチンおよび治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・mRNAワクチンおよび治療薬の世界市場規模 ・mRNAワクチンおよび治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・mRNAワクチンおよび治療薬のアメリカ市場規模推移 ・mRNAワクチンおよび治療薬のカナダ市場規模推移 ・mRNAワクチンおよび治療薬のメキシコ市場規模推移 ・mRNAワクチンおよび治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global mRNA Vaccine And Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of mRNA Vaccine And Therapeutics. Europe also play important...
  • バイオ医薬品ドラッグデリバリーデバイスの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9102919 / GlobalInfoResearch / 2019年9月23日 / 本調査レポートは、バイオ医薬品ドラッグデリバリーデバイスの世界市場について調べ、まとめました。種類別セグメントは、注射タイプ、粘膜タイプ、移植タイプ、その他のタイプ等、用途別セグメントは、製薬産業、臨床診断、科学研究、その他等に区分しました。バイオ医薬品ドラッグデリバリーデバイスの世界市場概観、メーカー動向、メーカー別バイオ医薬品ドラッグデリバリーデバイスシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・バイオ医薬品ドラッグデリバリーデバイスの市場概観 ・バイオ医薬品ドラッグデリバリーデバイスの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・バイオ医薬品ドラッグデリバリーデバイスの企業別販売動向、市場シェア、市場集中度、競争動向 ・バイオ医薬品ドラッグデリバリーデバイスの世界市場規模 ・バイオ医薬品ドラッグデリバリーデバイスの北米市場分析（アメリカ、カナダ、メキシコ等） ・バイオ医薬品ドラッグデリバリーデバイスのアメリカ市場規模推移 ・バイオ医薬品ドラッグデリバリーデバイスのカナダ市場規模推移 ・バイオ医薬品ドラッグデリバリーデバイスのメキシコ市場規模推移 ・バイオ医薬品ドラッグデリバリーデバイスのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Scope of the Report: The worldwide market for Biopharmaceutical Drug Delivery Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Biopharmaceutical Drug Delivery Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market...
  • 豚熱ワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101197 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、豚熱ワクチンの世界市場について調べ、まとめました。種類別セグメントは、組織培養起源、細胞株起源等、用途別セグメントは、政府入札、市場販売等に区分しました。豚熱ワクチンの世界市場概観、メーカー動向、メーカー別豚熱ワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・豚熱ワクチンの市場概観 ・豚熱ワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・豚熱ワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・豚熱ワクチンの世界市場規模 ・豚熱ワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・豚熱ワクチンのアメリカ市場規模推移 ・豚熱ワクチンのカナダ市場規模推移 ・豚熱ワクチンのメキシコ市場規模推移 ・豚熱ワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Swine fever, also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). Scope of the Report: The worldwide market for Swine Fever Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info...
  • RNAワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101166 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、RNAワクチンの世界市場について調べ、まとめました。種類別セグメントは、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン等、用途別セグメントは、感染症、がん、その他等に区分しました。RNAワクチンの世界市場概観、メーカー動向、メーカー別RNAワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・RNAワクチンの市場概観 ・RNAワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・RNAワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・RNAワクチンの世界市場規模 ・RNAワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・RNAワクチンのアメリカ市場規模推移 ・RNAワクチンのカナダ市場規模推移 ・RNAワクチンのメキシコ市場規模推移 ・RNAワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies. RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research...

    • ◆H&Iグローバルリサーチのお客様（例）◆